Integrating clinical trial landscapes and bibliometric analysis: unveiling the impact of PD-1/PD-L1 inhibitors on renal cell carcinoma research and therapeutic trajectories summary. The gene discussed is PDCD1; the disease is hereditary clear cell renal cell carcinoma.